Characterization of Septal Scar After Left Bundle Branch Area Pacemaker Implantation
Pacing and Clinical Electrophysiology · 2025-07 · 48 (7) · 765-775
DOI: 10.1111/pace.15211 ↗At a glance
Journal article in Pacing and Clinical Electrophysiology, published online on 2025-06-04. Written by Ilya Y Shadrin and 9 co-authors. Institution: Division of Cardiology, Department of Medicine, Duke University Hospital, Durham, North Carolina, USA. Major MEDLINE topics: Cicatrix, Pacemaker, Artificial, Heart Septum, Cardiac Pacing, Artificial. Cited 1 times so far (Crossref); 24 references. Funded by: Boston Scientific Corporation.
Abstract (original language)
Background
Left bundle branch area pacing (LBBAP) is increasingly used in patients with a ventricular pacing indication but necessitates precise septal localization. The resulting effects of intraoperative lead repositioning on septal fibrosis remain unknown.
Objective
To assess the safety of cardiac magnetic resonance imaging (cMRI) in patients with LBBAP pacemakers and evaluate the septal myocardium via cMRI following LBBAP implantation compared with standard RV endocardial pacing (RVP).
Methods
Patients aged > 18 y.o. with bradycardia, LBBAP or RVP implant from 2021 to 2023, and at least one cMRI after implant were identified. LBBAP versus RVP was verified per established criteria. Delayed‐enhancement cMRI and native T1 relaxation times were used to characterize myocardial scar.
Results
A total of 34 patients were identified—20 with LBBAP implants (9 with matched pre‐implant cMRI) and 14 with RVP implants (3 with matched pre‐implant cMRI)—with no evidence of ventricular septal defects post‐implant. LBBAP lead parameters were stable pre‐/post‐cMRI and out to 9 months. Comparing pre‐ versus post‐implant cMRIs (median 579 days apart), 1/9 patients following LBBAP showed a new scar on the RV inferoseptal side directly adjacent to the pacing lead on post‐implant cMRI, suggestive of potential implant‐related scarring with LBBAP.
Conclusion
CMRI appears safe for patients with LBBAP pacemakers, with stable short‐ and long‐term device parameters. In patients with matched pre/post‐implant cMRIs, the new septal scar can be identified with LBBAP implantation, raising the possibility of lead‐related fibrosis. Larger studies are required to substantiate whether the single case of lead‐related fibrosis is an exception or occurs more frequently.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Division of Cardiology, Department of Medicine, Duke University Hospital, Durham, North Carolina, USA.
- Duke Clinical Research Institute, Durham, North Carolina, USA.
- Duke Cardiovascular Magnetic Resonance Center, Durham, North Carolina, USA.
ORCID profiles: Ilya Y Shadrin, Jonathan P Piccini
Funding
- Boston Scientific Corporation
Cite
APA
Shadrin, I. Y., Wendell, D. C., Alenezi, F., Coles, S. A., Al-Khatib, S. M., Loring, Z., Piccini, J. P., Sun, A. Y., Hegland, D. D., & Friedman, D. J. (2025). Characterization of Septal Scar After Left Bundle Branch Area Pacemaker Implantation. Pacing and Clinical Electrophysiology, 48(7), 765-775. https://doi.org/10.1111/pace.15211
Vancouver
Shadrin IY, Wendell DC, Alenezi F, Coles SA, Al-Khatib SM, Loring Z, et al. Characterization of Septal Scar After Left Bundle Branch Area Pacemaker Implantation. Pacing and Clinical Electrophysiology. 2025;48(7):765-775. doi:10.1111/pace.15211
BibTeX
@article{Shadrin2025,
author = {Shadrin, Ilya Y and Wendell, David C and Alenezi, Fawaz and Coles, Sara A and Al-Khatib, Sana M and Loring, Zak and Piccini, Jonathan P and Sun, Albert Y and Hegland, Donald D and Friedman, Daniel J},
title = {Characterization of Septal Scar After Left Bundle Branch Area Pacemaker Implantation},
journal = {Pacing and Clinical Electrophysiology},
year = {2025},
volume = {48},
number = {7},
pages = {765--775},
doi = {10.1111/pace.15211}
}
EUVIMED